SCHEMBL4278528

SCHEMBL4278528

CC(=CC1(C=O)CO1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1074553 0.89 PTGS1 (0.32)
SCHEMBL7714153 0.79
SCHEMBL16499878 0.73 CD81 (0.32)
SCHEMBL16499876 0.73 CD81 (0.32)
SCHEMBL726326 0.70 CD81 (0.30)
SCHEMBL5713049 0.68 PTGS1 (0.31)
SCHEMBL28109278 0.68 AKR1C3 (0.32)
SCHEMBL3392711 0.65
SCHEMBL782181 0.65
SCHEMBL3288566 0.65 FFAR3 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994088-B1 IMPROVED COMPOSITIONS FOR ENDODONTIC INSTRUMENTS DENTSPLY SIRONA INC (US) 2024-02-14 EP claimed
EP-2204419-B1 BIOCOMPATIBLE POLYCARBONATE AND RADIOPAQUE POLYMER COMPOSITIONS AND METHODS OF MANUFACTURING MEDICAL DEVICES WITH SAME ST JUDE MEDICAL ATRIAL FIBRILL (US) 2016-08-31 EP claimed
EP-0952216-B1 Solid phase supports with PNA and amidate tag compliments LYNX THERAPEUTICS INC (US) 2005-08-17 EP claimed
US-11045833-B2 Task specific ionic liquid-impregnated polymeric surface coatings for antibacterial, antifouling, and metal scavenging activity MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-06-29 US disclosed
US-9273354-B2 System and apparatus for sequential processing of analytes ILLUMINA, INC. (US) 2016-03-01 US disclosed
CN-104398496-A Once-a-day replacement transdermal administration of fentanyl ALZA CORP 2015-03-11 CN disclosed
CN-101902996-B Once-a-day replacement transdermal administration of fentanyl ALZA CORP 2014-11-26 CN disclosed
US-20140213464-A1 SYSTEM AND APPARATUS FOR SEQUENTIAL PROCESSING OF ANALYTES ILLUMINA, INC. (US) 2014-07-31 US disclosed
US-8728729-B2 Method for sequential sequencing nucleic acids ILLUMINA, INC. (US) 2014-05-20 US disclosed
US-20130184162-A1 SYSTEM AND APPARATUS FOR SEQUENTIAL PROCESSING OF ANALYTES ILLUMINA, INC. (US) 2013-07-18 US disclosed
CN-101351335-B Multilayer fluoropolymer films ARKEMA INC 2013-05-15 CN disclosed
US-20020051992-A1 Device for the analysis and monitoring of multiple samples on a solid support LYNX THERAPEUTICS, INC. (US) 2002-05-02 US disclosed
EP-1162276-A2 MRNA molecules to be used as indicators of the functional and activational state of T-lymphocytes Lynx Therapeutics GmbH (DE) 2001-12-12 EP disclosed
EP-1017847-A1 METHOD OF MAPPING RESTRICTION SITES IN POLYNUCLEOTIDES LYNX THERAPEUTICS, INC. (US) 2000-07-12 EP disclosed
EP-0985142-A2 SYSTEM AND APPARAUS FOR SEQUENTIAL PROCESSING OF ANALYTES LYNX THERAPEUTICS, INC. (US) 2000-03-15 EP disclosed
CN-1230226-A Sequencing by ligation of encoded adaptors LYNX THERAPEUTICS INC (US) 1999-09-29 CN disclosed
EP-0923650-A1 SEQUENCING BY LIGATION OF ENCODED ADAPTORS LYNX THERAPEUTICS, INC. (US) 1999-06-23 EP disclosed
WO-1999000519-A1 METHOD OF MAPPING RESTRICTION SITES IN POLYNUCLEOTIDES LYNX THERAPEUTICS, INC. (US) 1999-01-07 WO disclosed
WO-1998053300-A2 SYSTEM AND APPARAUS FOR SEQUENTIAL PROCESSING OF ANALYTES LYNX THERAPEUTICS, INC. (US) 1998-11-26 WO disclosed
WO-1997046704-A1 SEQUENCING BY LIGATION OF ENCODED ADAPTORS LYNX THERAPEUTICS, INC. (US) 1997-12-11 WO disclosed